These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22393284

  • 1. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.
    Cao X, Deng WW, Fu M, Wang L, Tong SS, Wei YW, Xu Y, Su WY, Xu XM, Yu JN.
    Int J Nanomedicine; 2012; 7():753-62. PubMed ID: 22393284
    [Abstract] [Full Text] [Related]

  • 2. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs.
    Cao X, Deng W, Fu M, Zhu Y, Liu H, Wang L, Zeng J, Wei Y, Xu X, Yu J.
    Eur J Pharm Sci; 2013 Jan 23; 48(1-2):64-71. PubMed ID: 23123331
    [Abstract] [Full Text] [Related]

  • 3. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T, Geng T, Md A, Banerjee P, Wang B.
    Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of Pore-Size-Tunable Mesoporous Silica Nanoparticles by Simultaneous Sol-Gel and Radical Polymerization to Enhance Silibinin Dissolution.
    Shafiee M, Abolmaali S, Abedanzadeh M, Abedi M, Tamaddon A.
    Iran J Med Sci; 2021 Nov 01; 46(6):475-486. PubMed ID: 34840388
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH, Smått JH, Govardhanam NP, Ibrahim HM, Ismael HR, Afouna MI, Samy AM, Rosenholm JM.
    Eur J Pharm Sci; 2020 Jan 15; 142():105103. PubMed ID: 31648050
    [Abstract] [Full Text] [Related]

  • 8. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X, Chen L, Velleman L, Li C, Zhu H, He C, Wang T, Shigdar S, Duan W, Kong L.
    J Colloid Interface Sci; 2015 May 01; 445():151-160. PubMed ID: 25617610
    [Abstract] [Full Text] [Related]

  • 9. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D, Zhu ZQ, Tang HX, Shi ZE, Kang J, Liu Q, Qi J.
    Theranostics; 2020 May 01; 10(21):9808-9829. PubMed ID: 32863961
    [Abstract] [Full Text] [Related]

  • 10. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C.
    Int J Pharm; 2013 Sep 15; 454(1):135-42. PubMed ID: 23871738
    [Abstract] [Full Text] [Related]

  • 13. In Vitro Release and Bioavailability of Silybin from Micelle-Templated Porous Calcium Phosphate Microparticles.
    Zhu Y, Wang M, Zhang Y, Zeng J, Omari-Siaw E, Yu J, Xu X.
    AAPS PharmSciTech; 2016 Oct 15; 17(5):1232-9. PubMed ID: 26669888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
    Xu H, Zhang H, Wang D, Wu L, Liu X, Jiao Z.
    J Colloid Interface Sci; 2015 Aug 01; 451():101-7. PubMed ID: 25890118
    [Abstract] [Full Text] [Related]

  • 16. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y, Gou K, Yang B, Wang Y, Pu X, Li S, Li H.
    Molecules; 2019 Sep 30; 24(19):. PubMed ID: 31575047
    [Abstract] [Full Text] [Related]

  • 17. Engineering hollow mesoporous silica nanoparticles to increase cytotoxicity.
    Pérez-Garnes M, Gutiérrez-Salmerón M, Morales V, Chocarro-Calvo A, Sanz R, García-Jiménez C, García-Muñoz RA.
    Mater Sci Eng C Mater Biol Appl; 2020 Jul 30; 112():110935. PubMed ID: 32409082
    [Abstract] [Full Text] [Related]

  • 18. Hollow mesoporous silica nanoparticles-loaded ion-crosslinked bilayer films with excellent mechanical properties and high bioavailability for buccal delivery.
    Wang S, Jiang L, Meng S, Liu C, Wang H, Gao Z, Guo J.
    Int J Pharm; 2022 Aug 25; 624():122056. PubMed ID: 35905934
    [Abstract] [Full Text] [Related]

  • 19. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, Wang S.
    Int J Pharm; 2016 Aug 20; 510(1):184-94. PubMed ID: 27262268
    [Abstract] [Full Text] [Related]

  • 20. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H, Chen W, Xu ZP, Qian G, An J, Zhang H.
    Chemistry; 2017 Aug 10; 23(45):10878-10885. PubMed ID: 28580592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.